loader
Please Wait
Applying Filters...

Athena Athena

X

List of All Manufacturers & Suppliers for 2024217 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 INSULIN INJECTION HUMAN BIOSYNTHETIC (1)

02 INSULIN ISOPHANE HUMAN BIOSYNTHETIC (1)

filter

01 NOVO NORDISK CANADA INC (2)

filter

01 SUSPENSION (2)

filter

01 30UNIT/ML (1)

02 70UNIT/ML (1)

filter

01 Canada (2)

URL Supplier Web Content
SUSPENSION
70UNIT/ML
NOVOLIN GE 30/70
Canada
2024217
10ML
Schedule D
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SUSPENSION
30UNIT/ML
NOVOLIN GE 30/70
Canada
2024217
10ML
Schedule D
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 2024217

Looking for CTD TGA MCC DOSSIER APPLICATION 2024217 2

19

Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is INSULIN ISOPHANE HUMAN BIOSYNTHETIC, with a corresponding application number 2024217 and regulatory information .

proudly manufactured in the

Novo Nordisk's NOVOLIN GE 30/70 SUSPENSION, medication with 70UNIT/ML of INSULIN ISOPHANE HUMAN BIOSYNTHETIC.

18

Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is INSULIN INJECTION HUMAN BIOSYNTHETIC, with a corresponding application number 2024217 and regulatory information .

proudly manufactured in the

Novo Nordisk's NOVOLIN GE 30/70 SUSPENSION, medication with 30UNIT/ML of INSULIN INJECTION HUMAN BIOSYNTHETIC.

Post Enquiry
POST ENQUIRY